nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLC22A1—Cladribine—multiple sclerosis	0.0786	0.1	CbGbCtD
Nelfinavir—ABCG2—Cladribine—multiple sclerosis	0.0668	0.0852	CbGbCtD
Nelfinavir—SLCO1A2—Prednisolone—multiple sclerosis	0.0572	0.0729	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—multiple sclerosis	0.054	0.0689	CbGbCtD
Nelfinavir—ABCG2—Mitoxantrone—multiple sclerosis	0.0487	0.0622	CbGbCtD
Nelfinavir—CYP2D6—Fingolimod—multiple sclerosis	0.0352	0.0449	CbGbCtD
Nelfinavir—SLCO1A2—Dexamethasone—multiple sclerosis	0.0337	0.043	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—multiple sclerosis	0.0271	0.0346	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—multiple sclerosis	0.0256	0.0326	CbGbCtD
Nelfinavir—ABCG2—Dexamethasone—multiple sclerosis	0.0253	0.0322	CbGbCtD
Nelfinavir—ABCB1—Methylprednisolone—multiple sclerosis	0.0241	0.0307	CbGbCtD
Nelfinavir—CYP3A4—Fingolimod—multiple sclerosis	0.0224	0.0286	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—multiple sclerosis	0.0203	0.0259	CbGbCtD
Nelfinavir—CYP3A7—Dexamethasone—multiple sclerosis	0.0187	0.0238	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0187	0.0238	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—multiple sclerosis	0.0181	0.0231	CbGbCtD
Nelfinavir—CYP2B6—Dexamethasone—multiple sclerosis	0.0178	0.0227	CbGbCtD
Nelfinavir—ABCB1—Mitoxantrone—multiple sclerosis	0.0176	0.0224	CbGbCtD
Nelfinavir—ABCB1—Betamethasone—multiple sclerosis	0.0157	0.02	CbGbCtD
Nelfinavir—ABCB1—Prednisolone—multiple sclerosis	0.0155	0.0197	CbGbCtD
Nelfinavir—ABCB1—Prednisone—multiple sclerosis	0.0146	0.0186	CbGbCtD
Nelfinavir—CYP3A4—Methylprednisolone—multiple sclerosis	0.0144	0.0184	CbGbCtD
Nelfinavir—CYP3A5—Dexamethasone—multiple sclerosis	0.014	0.0179	CbGbCtD
Nelfinavir—CYP2C19—Dexamethasone—multiple sclerosis	0.0113	0.0144	CbGbCtD
Nelfinavir—CYP3A4—Triamcinolone—multiple sclerosis	0.0109	0.014	CbGbCtD
Nelfinavir—CYP3A4—Mitoxantrone—multiple sclerosis	0.0105	0.0134	CbGbCtD
Nelfinavir—CYP2C9—Dexamethasone—multiple sclerosis	0.00939	0.012	CbGbCtD
Nelfinavir—CYP3A4—Betamethasone—multiple sclerosis	0.00939	0.012	CbGbCtD
Nelfinavir—CYP3A4—Prednisolone—multiple sclerosis	0.00926	0.0118	CbGbCtD
Nelfinavir—ABCB1—Dexamethasone—multiple sclerosis	0.00911	0.0116	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—multiple sclerosis	0.00875	0.0112	CbGbCtD
Nelfinavir—CYP2D6—Dexamethasone—multiple sclerosis	0.00859	0.0109	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—multiple sclerosis	0.00732	0.00934	CbGbCtD
Nelfinavir—CYP3A4—Dexamethasone—multiple sclerosis	0.00546	0.00696	CbGbCtD
Nelfinavir—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00023	0.00129	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—multiple sclerosis	0.000227	0.00127	CcSEcCtD
Nelfinavir—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000227	0.00127	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000226	0.00127	CcSEcCtD
Nelfinavir—Pain—Mitoxantrone—multiple sclerosis	0.000226	0.00127	CcSEcCtD
Nelfinavir—Diarrhoea—Azathioprine—multiple sclerosis	0.000224	0.00126	CcSEcCtD
Nelfinavir—Discomfort—Prednisolone—multiple sclerosis	0.000223	0.00125	CcSEcCtD
Nelfinavir—Haemoglobin—Prednisone—multiple sclerosis	0.000223	0.00125	CcSEcCtD
Nelfinavir—Haemorrhage—Prednisone—multiple sclerosis	0.000222	0.00124	CcSEcCtD
Nelfinavir—Erythema—Betamethasone—multiple sclerosis	0.000222	0.00124	CcSEcCtD
Nelfinavir—Erythema—Dexamethasone—multiple sclerosis	0.000222	0.00124	CcSEcCtD
Nelfinavir—Malaise—Triamcinolone—multiple sclerosis	0.00022	0.00124	CcSEcCtD
Nelfinavir—Malaise—Methylprednisolone—multiple sclerosis	0.00022	0.00123	CcSEcCtD
Nelfinavir—Connective tissue disorder—Prednisone—multiple sclerosis	0.000218	0.00122	CcSEcCtD
Nelfinavir—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000218	0.00122	CcSEcCtD
Nelfinavir—Oedema—Prednisolone—multiple sclerosis	0.000217	0.00122	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—multiple sclerosis	0.000216	0.00122	CcSEcCtD
Nelfinavir—Dizziness—Azathioprine—multiple sclerosis	0.000216	0.00121	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000216	0.00121	CcSEcCtD
Nelfinavir—Convulsion—Triamcinolone—multiple sclerosis	0.000212	0.00119	CcSEcCtD
Nelfinavir—Convulsion—Methylprednisolone—multiple sclerosis	0.000211	0.00119	CcSEcCtD
Nelfinavir—Urticaria—Mitoxantrone—multiple sclerosis	0.00021	0.00118	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000209	0.00118	CcSEcCtD
Nelfinavir—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000209	0.00117	CcSEcCtD
Nelfinavir—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000209	0.00117	CcSEcCtD
Nelfinavir—Myalgia—Triamcinolone—multiple sclerosis	0.000208	0.00117	CcSEcCtD
Nelfinavir—Vomiting—Azathioprine—multiple sclerosis	0.000208	0.00117	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—multiple sclerosis	0.000208	0.00117	CcSEcCtD
Nelfinavir—Myalgia—Methylprednisolone—multiple sclerosis	0.000207	0.00116	CcSEcCtD
Nelfinavir—Arthralgia—Methylprednisolone—multiple sclerosis	0.000207	0.00116	CcSEcCtD
Nelfinavir—Eye disorder—Prednisone—multiple sclerosis	0.000207	0.00116	CcSEcCtD
Nelfinavir—Anxiety—Methylprednisolone—multiple sclerosis	0.000207	0.00116	CcSEcCtD
Nelfinavir—Rash—Azathioprine—multiple sclerosis	0.000206	0.00116	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000206	0.00116	CcSEcCtD
Nelfinavir—Dermatitis—Azathioprine—multiple sclerosis	0.000206	0.00116	CcSEcCtD
Nelfinavir—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000206	0.00115	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000206	0.00115	CcSEcCtD
Nelfinavir—Discomfort—Triamcinolone—multiple sclerosis	0.000205	0.00115	CcSEcCtD
Nelfinavir—Discomfort—Methylprednisolone—multiple sclerosis	0.000205	0.00115	CcSEcCtD
Nelfinavir—Headache—Azathioprine—multiple sclerosis	0.000205	0.00115	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—multiple sclerosis	0.000201	0.00113	CcSEcCtD
Nelfinavir—Angiopathy—Prednisone—multiple sclerosis	0.000201	0.00113	CcSEcCtD
Nelfinavir—Immune system disorder—Prednisone—multiple sclerosis	0.0002	0.00112	CcSEcCtD
Nelfinavir—Malaise—Betamethasone—multiple sclerosis	0.0002	0.00112	CcSEcCtD
Nelfinavir—Malaise—Dexamethasone—multiple sclerosis	0.0002	0.00112	CcSEcCtD
Nelfinavir—Oedema—Triamcinolone—multiple sclerosis	0.000199	0.00112	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—multiple sclerosis	0.000198	0.00111	CcSEcCtD
Nelfinavir—Insomnia—Prednisolone—multiple sclerosis	0.000196	0.0011	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000195	0.0011	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—multiple sclerosis	0.000195	0.00109	CcSEcCtD
Nelfinavir—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000195	0.00109	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisolone—multiple sclerosis	0.000195	0.00109	CcSEcCtD
Nelfinavir—Nausea—Azathioprine—multiple sclerosis	0.000194	0.00109	CcSEcCtD
Nelfinavir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000193	0.00108	CcSEcCtD
Nelfinavir—Erythema—Prednisone—multiple sclerosis	0.000193	0.00108	CcSEcCtD
Nelfinavir—Malnutrition—Prednisone—multiple sclerosis	0.000193	0.00108	CcSEcCtD
Nelfinavir—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000193	0.00108	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000192	0.00108	CcSEcCtD
Nelfinavir—Convulsion—Betamethasone—multiple sclerosis	0.000192	0.00108	CcSEcCtD
Nelfinavir—Convulsion—Dexamethasone—multiple sclerosis	0.000192	0.00108	CcSEcCtD
Nelfinavir—Asthenia—Mitoxantrone—multiple sclerosis	0.000189	0.00106	CcSEcCtD
Nelfinavir—Myalgia—Dexamethasone—multiple sclerosis	0.000189	0.00106	CcSEcCtD
Nelfinavir—Myalgia—Betamethasone—multiple sclerosis	0.000189	0.00106	CcSEcCtD
Nelfinavir—Anxiety—Betamethasone—multiple sclerosis	0.000188	0.00106	CcSEcCtD
Nelfinavir—Anxiety—Dexamethasone—multiple sclerosis	0.000188	0.00106	CcSEcCtD
Nelfinavir—Discomfort—Dexamethasone—multiple sclerosis	0.000186	0.00105	CcSEcCtD
Nelfinavir—Discomfort—Betamethasone—multiple sclerosis	0.000186	0.00105	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—multiple sclerosis	0.000186	0.00105	CcSEcCtD
Nelfinavir—Pain—Prednisolone—multiple sclerosis	0.000185	0.00104	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—multiple sclerosis	0.000185	0.00104	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—multiple sclerosis	0.000185	0.00104	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—multiple sclerosis	0.000184	0.00103	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000182	0.00102	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000181	0.00102	CcSEcCtD
Nelfinavir—Oedema—Betamethasone—multiple sclerosis	0.000181	0.00102	CcSEcCtD
Nelfinavir—Oedema—Dexamethasone—multiple sclerosis	0.000181	0.00102	CcSEcCtD
Nelfinavir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000181	0.00102	CcSEcCtD
Nelfinavir—Insomnia—Triamcinolone—multiple sclerosis	0.00018	0.00101	CcSEcCtD
Nelfinavir—Insomnia—Methylprednisolone—multiple sclerosis	0.00018	0.00101	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—multiple sclerosis	0.000179	0.00101	CcSEcCtD
Nelfinavir—Paraesthesia—Triamcinolone—multiple sclerosis	0.000179	0.00101	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisolone—multiple sclerosis	0.000179	0.001	CcSEcCtD
Nelfinavir—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000179	0.001	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—multiple sclerosis	0.000178	0.001	CcSEcCtD
Nelfinavir—Dyspnoea—Triamcinolone—multiple sclerosis	0.000178	0.000998	CcSEcCtD
Nelfinavir—Agitation—Prednisone—multiple sclerosis	0.000177	0.000996	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000177	0.000994	CcSEcCtD
Nelfinavir—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000177	0.000994	CcSEcCtD
Nelfinavir—Dyspepsia—Triamcinolone—multiple sclerosis	0.000175	0.000985	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—multiple sclerosis	0.000175	0.000984	CcSEcCtD
Nelfinavir—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000175	0.000983	CcSEcCtD
Nelfinavir—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000175	0.000982	CcSEcCtD
Nelfinavir—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000175	0.000982	CcSEcCtD
Nelfinavir—Malaise—Prednisone—multiple sclerosis	0.000174	0.000977	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—multiple sclerosis	0.000173	0.000972	CcSEcCtD
Nelfinavir—Anorexia—Dexamethasone—multiple sclerosis	0.000172	0.000968	CcSEcCtD
Nelfinavir—Anorexia—Betamethasone—multiple sclerosis	0.000172	0.000968	CcSEcCtD
Nelfinavir—Urticaria—Prednisolone—multiple sclerosis	0.000172	0.000967	CcSEcCtD
Nelfinavir—Pain—Triamcinolone—multiple sclerosis	0.00017	0.000957	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—multiple sclerosis	0.000168	0.000944	CcSEcCtD
Nelfinavir—Vomiting—Mitoxantrone—multiple sclerosis	0.000168	0.000943	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—multiple sclerosis	0.000167	0.00094	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—multiple sclerosis	0.000167	0.000939	CcSEcCtD
Nelfinavir—Rash—Mitoxantrone—multiple sclerosis	0.000167	0.000935	CcSEcCtD
Nelfinavir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000166	0.000934	CcSEcCtD
Nelfinavir—Headache—Mitoxantrone—multiple sclerosis	0.000165	0.000929	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000165	0.000925	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000165	0.000925	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—multiple sclerosis	0.000164	0.000923	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—multiple sclerosis	0.000164	0.000923	CcSEcCtD
Nelfinavir—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000164	0.000922	CcSEcCtD
Nelfinavir—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000164	0.00092	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—multiple sclerosis	0.000164	0.000919	CcSEcCtD
Nelfinavir—Insomnia—Betamethasone—multiple sclerosis	0.000164	0.000919	CcSEcCtD
Nelfinavir—Insomnia—Dexamethasone—multiple sclerosis	0.000164	0.000919	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000163	0.000916	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000163	0.000913	CcSEcCtD
Nelfinavir—Paraesthesia—Betamethasone—multiple sclerosis	0.000162	0.000912	CcSEcCtD
Nelfinavir—Paraesthesia—Dexamethasone—multiple sclerosis	0.000162	0.000912	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—multiple sclerosis	0.000162	0.000912	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—multiple sclerosis	0.000161	0.000906	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—multiple sclerosis	0.000161	0.000906	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisolone—multiple sclerosis	0.00016	0.000897	CcSEcCtD
Nelfinavir—Dyspepsia—Dexamethasone—multiple sclerosis	0.000159	0.000894	CcSEcCtD
Nelfinavir—Dyspepsia—Betamethasone—multiple sclerosis	0.000159	0.000894	CcSEcCtD
Nelfinavir—Urticaria—Triamcinolone—multiple sclerosis	0.000158	0.000889	CcSEcCtD
Nelfinavir—Urticaria—Methylprednisolone—multiple sclerosis	0.000158	0.000887	CcSEcCtD
Nelfinavir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000158	0.000885	CcSEcCtD
Nelfinavir—Oedema—Prednisone—multiple sclerosis	0.000157	0.000884	CcSEcCtD
Nelfinavir—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000157	0.000883	CcSEcCtD
Nelfinavir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000157	0.000883	CcSEcCtD
Nelfinavir—Decreased appetite—Betamethasone—multiple sclerosis	0.000157	0.000883	CcSEcCtD
Nelfinavir—Nausea—Mitoxantrone—multiple sclerosis	0.000157	0.000881	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000156	0.000877	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000156	0.000877	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—multiple sclerosis	0.000156	0.000876	CcSEcCtD
Nelfinavir—Pain—Betamethasone—multiple sclerosis	0.000155	0.000868	CcSEcCtD
Nelfinavir—Pain—Dexamethasone—multiple sclerosis	0.000155	0.000868	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—multiple sclerosis	0.000153	0.000859	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—multiple sclerosis	0.000152	0.000855	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—multiple sclerosis	0.00015	0.000843	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00015	0.00084	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—multiple sclerosis	0.000149	0.000837	CcSEcCtD
Nelfinavir—Feeling abnormal—Betamethasone—multiple sclerosis	0.000149	0.000837	CcSEcCtD
Nelfinavir—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000149	0.000837	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000148	0.00083	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000148	0.00083	CcSEcCtD
Nelfinavir—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000147	0.000825	CcSEcCtD
Nelfinavir—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000146	0.000823	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—multiple sclerosis	0.000145	0.000817	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—multiple sclerosis	0.000144	0.000811	CcSEcCtD
Nelfinavir—Urticaria—Betamethasone—multiple sclerosis	0.000144	0.000807	CcSEcCtD
Nelfinavir—Urticaria—Dexamethasone—multiple sclerosis	0.000144	0.000807	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000143	0.000806	CcSEcCtD
Nelfinavir—Dizziness—Prednisolone—multiple sclerosis	0.000143	0.000805	CcSEcCtD
Nelfinavir—Asthenia—Triamcinolone—multiple sclerosis	0.000143	0.000803	CcSEcCtD
Nelfinavir—Abdominal pain—Dexamethasone—multiple sclerosis	0.000143	0.000803	CcSEcCtD
Nelfinavir—Abdominal pain—Betamethasone—multiple sclerosis	0.000143	0.000803	CcSEcCtD
Nelfinavir—Body temperature increased—Betamethasone—multiple sclerosis	0.000143	0.000803	CcSEcCtD
Nelfinavir—Body temperature increased—Dexamethasone—multiple sclerosis	0.000143	0.000803	CcSEcCtD
Nelfinavir—Asthenia—Methylprednisolone—multiple sclerosis	0.000143	0.000801	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—multiple sclerosis	0.000142	0.0008	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—multiple sclerosis	0.000141	0.000794	CcSEcCtD
Nelfinavir—Pruritus—Triamcinolone—multiple sclerosis	0.000141	0.000792	CcSEcCtD
Nelfinavir—Pruritus—Methylprednisolone—multiple sclerosis	0.000141	0.00079	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—multiple sclerosis	0.00014	0.000785	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—multiple sclerosis	0.000139	0.000778	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—multiple sclerosis	0.000137	0.000771	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—multiple sclerosis	0.000137	0.000771	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—multiple sclerosis	0.000137	0.000769	CcSEcCtD
Nelfinavir—Rash—Prednisolone—multiple sclerosis	0.000137	0.000767	CcSEcCtD
Nelfinavir—Dermatitis—Prednisolone—multiple sclerosis	0.000136	0.000767	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000136	0.000766	CcSEcCtD
Nelfinavir—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000136	0.000764	CcSEcCtD
Nelfinavir—Headache—Prednisolone—multiple sclerosis	0.000136	0.000762	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—multiple sclerosis	0.000136	0.000762	CcSEcCtD
Nelfinavir—Dizziness—Triamcinolone—multiple sclerosis	0.000132	0.00074	CcSEcCtD
Nelfinavir—Dizziness—Methylprednisolone—multiple sclerosis	0.000131	0.000738	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—multiple sclerosis	0.00013	0.000729	CcSEcCtD
Nelfinavir—Asthenia—Betamethasone—multiple sclerosis	0.00013	0.000729	CcSEcCtD
Nelfinavir—Asthenia—Dexamethasone—multiple sclerosis	0.00013	0.000729	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000129	0.000724	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000129	0.000723	CcSEcCtD
Nelfinavir—Nausea—Prednisolone—multiple sclerosis	0.000129	0.000723	CcSEcCtD
Nelfinavir—Pruritus—Dexamethasone—multiple sclerosis	0.000128	0.000718	CcSEcCtD
Nelfinavir—Pruritus—Betamethasone—multiple sclerosis	0.000128	0.000718	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—multiple sclerosis	0.000128	0.000718	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000127	0.000715	CcSEcCtD
Nelfinavir—Vomiting—Triamcinolone—multiple sclerosis	0.000127	0.000712	CcSEcCtD
Nelfinavir—Vomiting—Methylprednisolone—multiple sclerosis	0.000126	0.00071	CcSEcCtD
Nelfinavir—Rash—Triamcinolone—multiple sclerosis	0.000126	0.000706	CcSEcCtD
Nelfinavir—Dermatitis—Triamcinolone—multiple sclerosis	0.000126	0.000705	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—multiple sclerosis	0.000125	0.000705	CcSEcCtD
Nelfinavir—Rash—Methylprednisolone—multiple sclerosis	0.000125	0.000704	CcSEcCtD
Nelfinavir—Dermatitis—Methylprednisolone—multiple sclerosis	0.000125	0.000703	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—multiple sclerosis	0.000125	0.000703	CcSEcCtD
Nelfinavir—Headache—Triamcinolone—multiple sclerosis	0.000125	0.000701	CcSEcCtD
Nelfinavir—Headache—Methylprednisolone—multiple sclerosis	0.000125	0.0007	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—multiple sclerosis	0.000124	0.000699	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—multiple sclerosis	0.000124	0.000699	CcSEcCtD
Nelfinavir—Diarrhoea—Dexamethasone—multiple sclerosis	0.000124	0.000695	CcSEcCtD
Nelfinavir—Diarrhoea—Betamethasone—multiple sclerosis	0.000124	0.000695	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00012	0.000673	CcSEcCtD
Nelfinavir—Dizziness—Dexamethasone—multiple sclerosis	0.00012	0.000672	CcSEcCtD
Nelfinavir—Dizziness—Betamethasone—multiple sclerosis	0.00012	0.000672	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—multiple sclerosis	0.000119	0.000668	CcSEcCtD
Nelfinavir—Nausea—Triamcinolone—multiple sclerosis	0.000118	0.000665	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—multiple sclerosis	0.000118	0.000664	CcSEcCtD
Nelfinavir—Nausea—Methylprednisolone—multiple sclerosis	0.000118	0.000663	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—multiple sclerosis	0.000117	0.000659	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—multiple sclerosis	0.000117	0.000657	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—multiple sclerosis	0.000116	0.000652	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—multiple sclerosis	0.000116	0.000651	CcSEcCtD
Nelfinavir—Vomiting—Betamethasone—multiple sclerosis	0.000115	0.000646	CcSEcCtD
Nelfinavir—Vomiting—Dexamethasone—multiple sclerosis	0.000115	0.000646	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—multiple sclerosis	0.000114	0.000643	CcSEcCtD
Nelfinavir—Rash—Betamethasone—multiple sclerosis	0.000114	0.00064	CcSEcCtD
Nelfinavir—Rash—Dexamethasone—multiple sclerosis	0.000114	0.00064	CcSEcCtD
Nelfinavir—Dermatitis—Betamethasone—multiple sclerosis	0.000114	0.00064	CcSEcCtD
Nelfinavir—Dermatitis—Dexamethasone—multiple sclerosis	0.000114	0.00064	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000114	0.000638	CcSEcCtD
Nelfinavir—Headache—Dexamethasone—multiple sclerosis	0.000113	0.000636	CcSEcCtD
Nelfinavir—Headache—Betamethasone—multiple sclerosis	0.000113	0.000636	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—multiple sclerosis	0.000113	0.000635	CcSEcCtD
Nelfinavir—Pain—Methotrexate—multiple sclerosis	0.000113	0.000632	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—multiple sclerosis	0.000111	0.000626	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—multiple sclerosis	0.000108	0.000609	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—multiple sclerosis	0.000108	0.000605	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000108	0.000604	CcSEcCtD
Nelfinavir—Nausea—Dexamethasone—multiple sclerosis	0.000107	0.000603	CcSEcCtD
Nelfinavir—Nausea—Betamethasone—multiple sclerosis	0.000107	0.000603	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—multiple sclerosis	0.000105	0.000587	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—multiple sclerosis	0.000104	0.000585	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—multiple sclerosis	0.000104	0.000584	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—multiple sclerosis	0.000104	0.000584	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—multiple sclerosis	0.0001	0.000562	CcSEcCtD
Nelfinavir—Rash—Prednisone—multiple sclerosis	9.93e-05	0.000558	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—multiple sclerosis	9.92e-05	0.000557	CcSEcCtD
Nelfinavir—Headache—Prednisone—multiple sclerosis	9.86e-05	0.000554	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—multiple sclerosis	9.69e-05	0.000545	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—multiple sclerosis	9.44e-05	0.00053	CcSEcCtD
Nelfinavir—Nausea—Prednisone—multiple sclerosis	9.35e-05	0.000525	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—multiple sclerosis	9.31e-05	0.000523	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—CD28—multiple sclerosis	9.17e-05	0.00242	CbGpPWpGaD
Nelfinavir—Diarrhoea—Methotrexate—multiple sclerosis	9e-05	0.000506	CcSEcCtD
Nelfinavir—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.84e-05	0.00234	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	8.77e-05	0.00232	CbGpPWpGaD
Nelfinavir—Dizziness—Methotrexate—multiple sclerosis	8.7e-05	0.000489	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	8.7e-05	0.0023	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	8.63e-05	0.00228	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	8.63e-05	0.00228	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.52e-05	0.00225	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.52e-05	0.00225	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.49e-05	0.00224	CbGpPWpGaD
Nelfinavir—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.4e-05	0.00222	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CD40—multiple sclerosis	8.37e-05	0.00221	CbGpPWpGaD
Nelfinavir—Vomiting—Methotrexate—multiple sclerosis	8.37e-05	0.00047	CcSEcCtD
Nelfinavir—Rash—Methotrexate—multiple sclerosis	8.3e-05	0.000466	CcSEcCtD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.3e-05	0.00219	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.3e-05	0.00219	CbGpPWpGaD
Nelfinavir—Dermatitis—Methotrexate—multiple sclerosis	8.29e-05	0.000466	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	8.25e-05	0.00218	CbGpPWpGaD
Nelfinavir—Headache—Methotrexate—multiple sclerosis	8.24e-05	0.000463	CcSEcCtD
Nelfinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.97e-05	0.00211	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.86e-05	0.00208	CbGpPWpGaD
Nelfinavir—Nausea—Methotrexate—multiple sclerosis	7.82e-05	0.000439	CcSEcCtD
Nelfinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.66e-05	0.00202	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.55e-05	0.002	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.54e-05	0.00199	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.52e-05	0.00199	CbGpPWpGaD
Nelfinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.49e-05	0.00198	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.26e-05	0.00192	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.25e-05	0.00192	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.12e-05	0.00188	CbGpPWpGaD
Nelfinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.1e-05	0.00188	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.79e-05	0.00179	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.66e-05	0.00176	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.66e-05	0.00176	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.57e-05	0.00174	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.57e-05	0.00174	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.54e-05	0.00173	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.43e-05	0.0017	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.41e-05	0.0017	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.41e-05	0.0017	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.24e-05	0.00165	CbGpPWpGaD
Nelfinavir—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.21e-05	0.00164	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—SRM—multiple sclerosis	6.13e-05	0.00162	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.1e-05	0.00161	CbGpPWpGaD
Nelfinavir—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.07e-05	0.0016	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.95e-05	0.00157	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.94e-05	0.00157	CbGpPWpGaD
Nelfinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.79e-05	0.00153	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.75e-05	0.00152	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.72e-05	0.00151	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.65e-05	0.00149	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.49e-05	0.00145	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—BCHE—multiple sclerosis	5.45e-05	0.00144	CbGpPWpGaD
Nelfinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.32e-05	0.00141	CbGpPWpGaD
Nelfinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.28e-05	0.00139	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.25e-05	0.00139	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—SRM—multiple sclerosis	5.24e-05	0.00139	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.16e-05	0.00136	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.08e-05	0.00134	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—SRM—multiple sclerosis	4.86e-05	0.00128	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—SRM—multiple sclerosis	4.81e-05	0.00127	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.77e-05	0.00126	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.71e-05	0.00124	CbGpPWpGaD
Nelfinavir—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.69e-05	0.00124	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.64e-05	0.00123	CbGpPWpGaD
Nelfinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.51e-05	0.00119	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.49e-05	0.00119	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—SRM—multiple sclerosis	4.48e-05	0.00118	CbGpPWpGaD
Nelfinavir—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.46e-05	0.00118	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.34e-05	0.00115	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	4.32e-05	0.00114	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	4.32e-05	0.00114	CbGpPWpGaD
Nelfinavir—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.32e-05	0.00114	CbGpPWpGaD
Nelfinavir—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.28e-05	0.00113	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.26e-05	0.00112	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.26e-05	0.00112	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.25e-05	0.00112	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.22e-05	0.00112	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.16e-05	0.0011	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.14e-05	0.00109	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.13e-05	0.00109	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.12e-05	0.00109	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—GPC5—multiple sclerosis	3.95e-05	0.00104	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.88e-05	0.00103	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.88e-05	0.00103	CbGpPWpGaD
Nelfinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.84e-05	0.00101	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.84e-05	0.00101	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.77e-05	0.000997	CbGpPWpGaD
Nelfinavir—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.72e-05	0.000984	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.69e-05	0.000976	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.69e-05	0.000976	CbGpPWpGaD
Nelfinavir—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.66e-05	0.000966	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.61e-05	0.000954	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SRM—multiple sclerosis	3.56e-05	0.000941	CbGpPWpGaD
Nelfinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.48e-05	0.00092	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SRM—multiple sclerosis	3.48e-05	0.000919	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP27B1—multiple sclerosis	3.42e-05	0.000904	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP24A1—multiple sclerosis	3.42e-05	0.000904	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.39e-05	0.000896	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.39e-05	0.000896	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GPC5—multiple sclerosis	3.38e-05	0.000893	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.36e-05	0.000889	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.35e-05	0.000886	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.32e-05	0.000876	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.32e-05	0.000876	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.32e-05	0.000876	CbGpPWpGaD
Nelfinavir—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.3e-05	0.000872	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—RRM1—multiple sclerosis	3.27e-05	0.000865	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.22e-05	0.000852	CbGpPWpGaD
Nelfinavir—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.22e-05	0.000852	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.22e-05	0.000851	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.22e-05	0.00085	CbGpPWpGaD
Nelfinavir—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.18e-05	0.000841	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.16e-05	0.000834	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.16e-05	0.000834	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.15e-05	0.000834	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GPC5—multiple sclerosis	3.13e-05	0.000827	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.1e-05	0.00082	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3e-05	0.000794	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3e-05	0.000794	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.89e-05	0.000763	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.84e-05	0.00075	CbGpPWpGaD
Nelfinavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.82e-05	0.000746	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.00074	CbGpPWpGaD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.72e-05	0.000719	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SRM—multiple sclerosis	2.69e-05	0.000711	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SRM—multiple sclerosis	2.63e-05	0.000694	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.61e-05	0.000691	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—RRM1—multiple sclerosis	2.59e-05	0.000685	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.57e-05	0.000679	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.54e-05	0.000672	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.54e-05	0.000671	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.51e-05	0.000663	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.51e-05	0.000663	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.49e-05	0.000659	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SRM—multiple sclerosis	2.47e-05	0.000654	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SRM—multiple sclerosis	2.45e-05	0.000648	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.000648	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.000648	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.44e-05	0.000645	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.39e-05	0.000632	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.29e-05	0.000606	CbGpPWpGaD
Nelfinavir—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.29e-05	0.000606	CbGpPWpGaD
Nelfinavir—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.000601	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.25e-05	0.000594	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.000592	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.18e-05	0.000577	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.17e-05	0.000574	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SRM—multiple sclerosis	2.1e-05	0.000554	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.08e-05	0.00055	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.99e-05	0.000526	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.94e-05	0.000513	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.9e-05	0.000502	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.89e-05	0.000501	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.89e-05	0.000501	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.89e-05	0.0005	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.88e-05	0.000497	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.87e-05	0.000493	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.000491	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.85e-05	0.000489	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.85e-05	0.000489	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.85e-05	0.000489	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.74e-05	0.000461	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.74e-05	0.000461	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.73e-05	0.000458	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000457	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000457	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.7e-05	0.00045	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GPC5—multiple sclerosis	1.69e-05	0.000447	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.000446	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.62e-05	0.000428	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SRM—multiple sclerosis	1.62e-05	0.000427	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000425	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.59e-05	0.000421	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.59e-05	0.000421	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000418	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.5e-05	0.000396	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.5e-05	0.000396	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000394	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.00039	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.00039	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.48e-05	0.00039	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.44e-05	0.000381	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.00038	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RRM1—multiple sclerosis	1.4e-05	0.00037	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000365	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000363	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000357	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000349	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000346	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.29e-05	0.000342	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.29e-05	0.000341	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.27e-05	0.000334	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.2e-05	0.000318	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000301	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000301	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.13e-05	0.000299	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000296	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000294	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.09e-05	0.000288	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.000282	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.04e-05	0.000275	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	0.000268	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—POMC—multiple sclerosis	9.72e-06	0.000257	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—APOE—multiple sclerosis	9.67e-06	0.000256	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.57e-06	0.000253	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—APOE—multiple sclerosis	8.96e-06	0.000237	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—APOE—multiple sclerosis	8.88e-06	0.000235	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ALB—multiple sclerosis	8.86e-06	0.000234	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.73e-06	0.000231	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.73e-06	0.000231	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.68e-06	0.000229	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.64e-06	0.000228	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.31e-06	0.00022	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—APOE—multiple sclerosis	8.26e-06	0.000218	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.25e-06	0.000218	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.1e-06	0.000214	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—BCHE—multiple sclerosis	8.05e-06	0.000213	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.96e-06	0.00021	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—POMC—multiple sclerosis	7.7e-06	0.000203	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—POMC—multiple sclerosis	7.63e-06	0.000202	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.59e-06	0.0002	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.58e-06	0.0002	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.52e-06	0.000199	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.46e-06	0.000197	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—POMC—multiple sclerosis	7.1e-06	0.000188	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—multiple sclerosis	7.02e-06	0.000185	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—multiple sclerosis	6.95e-06	0.000184	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.8e-06	0.00018	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOE—multiple sclerosis	6.57e-06	0.000174	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—multiple sclerosis	6.47e-06	0.000171	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.43e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOE—multiple sclerosis	6.42e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—POMC—multiple sclerosis	5.64e-06	0.000149	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—POMC—multiple sclerosis	5.51e-06	0.000146	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—multiple sclerosis	5.14e-06	0.000136	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—multiple sclerosis	5.03e-06	0.000133	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOE—multiple sclerosis	4.96e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.96e-06	0.000131	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOE—multiple sclerosis	4.84e-06	0.000128	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOE—multiple sclerosis	4.56e-06	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOE—multiple sclerosis	4.52e-06	0.00012	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—POMC—multiple sclerosis	4.26e-06	0.000113	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—POMC—multiple sclerosis	4.16e-06	0.00011	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—POMC—multiple sclerosis	3.92e-06	0.000104	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—POMC—multiple sclerosis	3.89e-06	0.000103	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—multiple sclerosis	3.89e-06	0.000103	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOE—multiple sclerosis	3.87e-06	0.000102	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—multiple sclerosis	3.79e-06	0.0001	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—multiple sclerosis	3.57e-06	9.45e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—multiple sclerosis	3.54e-06	9.36e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—POMC—multiple sclerosis	3.32e-06	8.78e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—multiple sclerosis	3.03e-06	8e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOE—multiple sclerosis	2.98e-06	7.89e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—POMC—multiple sclerosis	2.56e-06	6.77e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—multiple sclerosis	2.34e-06	6.18e-05	CbGpPWpGaD
